BeStock  
Stocks › AXSM

Axsome Therapeutics AXSM

US equityMarket cap rank #1751
$129.36 −$6.32 (-4.66%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $129.36 0.00%
Open$133.92
Prev close$135.68
Day range$128.23 – $135.09
Volume811.8K
Market cap$6.80B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

AXSM at a glance

Shares of Axsome Therapeutics are down 4.66% at $129.36. The company is worth $6.80B, number 1751 out of 3753 on our list.

It is close to the bottom of its 52-week range ($123.00 to $260.19), 50.3% under the high. Holders are behind 13.4% over twelve months, and down 37.0% across the last three months.

On the chart it has slipped under both the 50-day ($163.75) and 200-day ($195.79) moving averages; RSI is 33, and the last 30 sessions moved at roughly 51% annualized volatility.

For the quarter ended Sep 2026 it reported $259.69M in revenue, up 51.9% from a year earlier, and a net loss of $12.88M.

17 analysts follow the stock and the average call is "buy". The mean target, $263.94, sits 104.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$125.40 / $131.20
Average price today$130.33
Volume811.8KAvg (90d) 821.8K
Turnover$105.80M
Turnover rate1.82%of shares outstanding
Volume ratio1.00vs. recent average pace
Day amplitude5.06%
Market cap$6.80B
Float market cap$5.78B
Shares outstanding44.68M
EPS (TTM)-$3.68
P/B64.55
Book value / share$2.00
Net profit (TTM)-$193.57M
Net assets$105.41M
30-day volatility50.8%annualized
Avg daily range (ATR)5.02%of price, 14 days
Max drawdown (1y)-49.3%-49.3% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

17 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 3.3 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation1.6
Growth—
Profitability18.8
Momentum11.3
Financial health11.5
Analyst view90.8

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$263.94+104.0% vs. current price
Consensus ratingBuy17 analysts covering
Morningstar fair value$140.06Price is below fair value

Wall Street’s average 12-month target is $263.94, 104.0% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $140.06, so shares trade 7.6% below that estimate. On earnings multiple, it sits in the 10th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-4.7%
1 week
-8.7%
1 month
-17.1%
3 months
-37.0%
6 months
-45.2%
Year to date
-29.2%
1 year
-13.4%
Day range
$128.23$135.09
52-week range
$123.00$260.19

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-6.8%Bearish
Price vs 50-day average-21.0%Bearish
Price vs 200-day average-33.9%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)32.9Bearish
MACD (12,26,9)-7.78Bullish
Bollinger band position7%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How AXSM ranks on BeStock

Market value#1746 of 3734
Closeness to 52-week high#3051 of 3724
Dollar volume today#970 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

AXSM is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on AXSM.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on AXSM

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

AXSM stock: common questions

What is AXSM's latest share price?

$129.36 is the latest print for AXSM, a move of -4.66% against yesterday's close of $135.68. Today's low and high so far: $128.23 and $135.09.

What is AXSM worth in total?

Equity value comes to $6.80B at the current price. By that measure it is number 1751 of the 3753 names in our coverage.

Where does AXSM sit in its 52-week range?

The year's floor is $123.00 and the ceiling $260.19. Shares are 50.3% away from that ceiling.

Does AXSM send cash back through a dividend?

Our data shows no dividend paid by Axsome Therapeutics over the trailing twelve months.

Do Wall Street analysts like AXSM?

Of 17 analysts, 94% say buy, 6% hold and 0% sell. Price targets average $263.94, with the most cautious at $220.00 and the most optimistic at $310.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on AXSM.

Sign in to join the discussion.

Scroll to Top